Nanobacteria are proposed to cause pathological calcification. Nanobac Pharmaceuticals is collaborating with Mayo Clinic, NASA, UCSF, and others to perform research.
The research to date PROVES that nanobacteria, more recently termed "calcifying nanoparticles or CNPs, are present in atherosclerotic lesions, kidney stones, and virtually all other calcium phosphate deposit diseases.
Nanobac developed a therapy that treat CNPs, but then stop selling it.
I found it at
http://www.cal-detox.com
It is now by prescription and is dispensed through the Westchase Compounding Pharmacy. The protocol is called Cal-Detox.
The treatment is comprised of an EDTA rectal suppository, tetracycline, and a dietary supplement.
Here are the links for anyone interested:
http://westchasepharmacy.com/caldetox.html
http://cal-detox.com/
|
|
|
2yourhealth
|
|